July 1, 2025
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. [...]
July 1, 2025
Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis [...]
July 1, 2025
SPECTRO Analytical Instruments has unveiled its new SPECTROGREEN MS Quadrupole Mass Spectrometer, an innovative ICP-MS solution engineered for high-performance, routine trace-level elemental analysis with unmatched ease of use. The SPECTROGREEN MS combines state-of-the-art technology with simplified workflows to address the needs of laboratories handling environmental, pharmaceutical, food, consumer product testing, and industrial applications. Highlights of [...]
July 1, 2025
Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way [...]
Siemens completes acquisition of Dotmatics
July 1, 2025
Acquisition successfully closed for enterprise value of $5.1 billion Siemens expands AI-powered Siemens Xcelerator portfolio with end-to-end digital thread that connects data from research through to production in Life Sciences Combined capabilities expected to accelerate scientific innovation and drive long-term growth Acquisition is another milestone of Siemens' ONE Tech Company program expanding Siemens' offerings into the [...]
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
July 1, 2025
Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development -- TOKYO -- The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHCbi"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as "PHCHD") announces it has signed an exclusive agreement with MaxCyte, Inc. [...]
Ad hoc announcement pursuant to Art. 53 LR — Zeochem to acquire SiliCycle of Canada
July 1, 2025
The Chemistry Division of the CPH Group has entered into an agreement to purchase all substantial assets of SiliCycle Inc., a Canada-based company. The acquisition of this manufacturer of high-value chromatography gels for the pharmaceutical industries marks a further milestone in the CPH Group’s implementation of its global expansion strategy. Perlen – The CPH Group [...]
June 30, 2025
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Portal Biotech [...]
Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions
June 30, 2025
Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM -- Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage [...]
June 30, 2025
Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, Sweden — Pixelgen Technologies today announced that it has been awarded grant and equity financing of EUR 12.5 M ($14.7 million) from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union’s Horizon Europe program designed to support highly innovative start-ups with [...]

